FinEdge Labs
L

LH

LHUnverified
2 segments tracked|8 years of data|Annual (10-K)
Total Revenue
$14.0B6.9%
FY2025
Operating Segments
2
Active segments
Blended Margin
16.3%
Operating margin
Highest Margin
16.4%
Diagnostics
Segment Shift

Diagnostics has grown from 100.0% to 77.8% of total revenue since FY2018, with 16.4% operating margins.

Segment Revenue Over Time

Revenue Mix

Segment Breakdown — FY2025

SegmentRevenueOp. IncomeMargin% of TotalYoY
Diagnostics$10.9B$1.8B16.4%77.8%+7.2%
Biopharma Laboratory Services$3.1B$499M16.1%22.2%+6.0%

Want more? Unlock the full analysis.

Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.

Get Started Free